Adherence is not a barrier to successful antiretroviral therapy in South Africa
- 1 June 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (9) , 1369-1375
- https://doi.org/10.1097/00002030-200306130-00011
Abstract
To determine adherence of an indigent African HIV-infected cohort initiating antiretroviral therapy (ART); to identify predictors of incomplete adherence (< 95%) and virologic failure (> 400 HIV RNA copies/ml). Prospective monitoring of adherence in a poor HIV-positive cohort, attending a public sector hospital and receiving ART through phase III studies. Adherence to ART was determined over 48 weeks by counting tablet-returns. Logistic regression models including age, WHO HIV stage, home language, socio-economic status, complexity and type of regimen were fitted to determine predictors of incomplete adherence and virologic failure at 48 weeks. 289 patients were recruited between January 1996 and May 2001. Median (mean) adherence of the cohort was 93.5% (87.2%). Three times daily dosing [risk ratio (RR), 3.07; 95% confidence interval (CI), 1.40-6.74], speaking English (RR, 0.41; 95% CI, 0.21-0.80) and age (RR, 0.97; 95% CI, 0.94-0.99) were independent predictors of incomplete adherence. Socio-economic status, sex and HIV stage did not predict adherence. Independent predictors of virologic failure included baseline viral load (RR, 2.57; 95% CI, 1.57-4.22) and three times daily dosing (RR, 2.64; 95% CI, 1.23-5.66), incomplete adherence (RR, 1.92; 95% CI, 1.10-3.57), age (RR, 0.96; 95% CI, 0.92-0.99) and dual nucleoside therapy (RR, 2.69; 95% CI, 1.17-6.15). The proportion of individuals achieving viral suppression matched results from the developing world. Speaking the same language as site staff and simplified dosing frequency were beneficial. Socio-economic status had no impact on adherence and should not be used as a limitation to ART access.Keywords
This publication has 19 references indexed in Scilit:
- Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-upAIDS, 2002
- Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapyAIDS, 2002
- Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Antiretroviral Therapy Adherence and Viral Suppression in HIV‐Infected Drug Users: Comparison of Self‐Report and Electronic MonitoringClinical Infectious Diseases, 2001
- Adherence to Highly Active Antiretroviral Therapy Predicts Virologic Outcome at an Inner‐City Human Immunodeficiency Virus ClinicClinical Infectious Diseases, 2001
- Preventing antiretroviral anarchy in sub-Saharan AfricaThe Lancet, 2001
- Non-adherence to highly active antiretroviral therapy predicts progression to AIDSAIDS, 2001
- A Comparison Study of Multiple Measures of Adherence to HIV Protease InhibitorsAnnals of Internal Medicine, 2001
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000
- Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent populationAIDS, 2000